Top Markets
#1 Nesa Nesa +798.54%
#2 Cortex Cortex +68.78%
#3 Kinesis Silver Kinesis Silver +55.88%
#4 Merlin's Seal BTC Merlin's Seal BTC +45.67%
#5 QuantixAI QuantixAI +24.00%
#6 EXOD EXOD +22.78%
#7 Cash Cat Cash Cat +22.65%
#8 OpenEden OpenEden +17.60%
#9 Instadapp Instadapp +16.15%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +15.81%
Coin of the day
Nesa Nesa
Settings
Language
ENGLISH
Currency
USD
Theme
YD Bio Limited Ordinary Shares YD Bio Limited Ordinary Shares

YD Bio Limited Ordinary Shares

YDES
Rank in Stocks #19458
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company... Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.
Share Price
$2.28
Last synced: 2026-07-31
Market Cap
$161.59M
Change (1 day)
3.70%
Change (1 year)
-82.92%
Country
TW
Trade YD Bio Limited Ordinary Shares (YDES)

Category

Healthcare
P/B ratio for YD Bio Limited Ordinary Shares (YDES)
P/B ratio as of 2026 TTM: 0
According to YD Bio Limited Ordinary Shares latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for YD Bio Limited Ordinary Shares from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH